Agile Therapeutics to Host First Analyst Day on October 10, 2017

Monday, October 2, 2017 11:30 AM UTC

PRINCETON, N.J., Oct. 02, 2017 -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday, October 10, 2017 in New York City.

Members of Agile’s executive team will review clinical data and discuss the commercialization plan for Twirla^®, the company's lead investigational once weekly low-dose prescription contraceptive patch. Management will be joined by leading external experts who will provide clinical perspectives on Twirla, as well as regulatory and market access insights into today’s contraceptive marketplace.

To access the live webcast, visit the Investor Relations section of Agile Therapeutics website at www.agiletherapeutics.com. A replay will be available on the company’s website.

Event Details

Date:	Tuesday, October 10, 2017
Time:	11:00 a.m. – 1:30 p.m. ET
Location:	New York City

Speakers will include:

Alfred Altomari	Chairman and CEO, Agile Therapeutics

Elizabeth Garner, M.D., MPH	Senior Vice President, Chief Medical Officer, Agile Therapeutics

Renee Selman	Chief Commercial Officer, Agile Therapeutics

Robin Kroll, M.D., FACOG	Director, Seattle Women’s: Health, Research, Gynecology;
	SECURE Trial Investigator

David J. Portman, M.D., FACOG	Director Emeritus, Columbus Center for Women’s Health
	Research; CEO and Chief Medical Officer, Sermonix
	Pharmaceuticals

Minnie Baylor-Henry, J.D., R.Ph	Executive Partner, YourEncore; Former Director, Division of
	Drug Marketing, Advertising and Communications (DDMAC),
	Food and Drug Administration; Former Worldwide Vice
	President, Regulatory Affairs, Johnson & Johnson

Adaeze Enekwechi, PhD, MPP	VP, McDermottPlus Consulting in Washington,D.C.; Former
	Associate Director for Health Programs, White House Office of
	Management and Budget under President Obama

Analysts and institutional investors seeking more information about this event should contact Matt Ventimigila by phone or email: [email protected], or 212-599-1265.

About Agile Therapeutics
Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our lead product candidate, Twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is a once-weekly prescription contraceptive patch that recently completed Phase 3 trials. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. For more information, please visit the company website at www.agiletherapeutics.com. The company may occasionally disseminate material, nonpublic information on the company website.

Follow Agile on Twitter: @agilether. The company may occasionally disseminate material, nonpublic information on the company website.

About Twirla^®
Twirla (ethinyl estradiol and levonorgestrel transdermal system) or AG200-15 is an investigational once-weekly prescription contraceptive patch. AG200-15 is a combined hormonal contraceptive (CHC) patch that contains the active ingredients ethinyl estradiol (EE), a synthetic estrogen, and levonorgestrel (LNG), a type of progestin, a synthetic steroid hormone. Twirla is designed to be applied once weekly for three weeks, followed by a week without a patch.

Contact:
Mary Coleman
Agile Therapeutics, Inc.
609-356-1921

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Agile Therapeutics to Host First Analyst Day on October 10, 2017

Editor's Picks

Welcome to EconoTimes